MAKSIMMAMONKINMAKSIM MAMONKIN0.000000000000000.000000000000004918MAMONKIN, MAKSIMAssociate Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 162688425734008Sun J, Huye LE, Lapteva N, Mamonkin M, Hiregange M, Ballard B, Dakhova O, Raghavan D, Durett AG, Perna SK, Omer B, Rollins LA, Leen AM, Vera JF, Dotti G, Gee AP, Brenner MK, Myers DG, Rooney CMJournal for immunotherapy of cancerEarly transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application. J Immunother Cancer. 2015; 3:5.J Immunother Cancer2015-02-18T00:00:002015Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application.Lymphoma-MyelomaMD AndersonSATTVA SNEELAPUSATTVA S NEELAPU9154NEELAPU, SATTVA SAssociate Professor26056165Mamonkin M, Rouce RH, Tashiro H, Brenner MKBloodA T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies. Blood. 2015 Aug 20; 126(8):983-92.Blood2015-06-08T00:00:002015A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies.Center for Cell & Gene TherapyAuthorship 281064174Professor10Assistant Professor14Associate Professor42Director78Professor Emeritus6Adjunct Professor47Distinguished Service Professor27427982Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed NThe Journal of clinical investigationTandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape. J Clin Invest. 2016 08 01; 126(8):3036-52.J Clin Invest2016-07-18T00:00:002016Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape.Authorship 324994181102 BATESHouston, 77030TX3.184970.00576507167research areas4.078540.046732236coauthor of106.612.686260similar to1143selected publications19412182Yamada T, Park CS, Mamonkin M, Lacorazza HDNature immunologyTranscription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Kr?ppel-like factors KLF4 and KLF2. Nat Immunol. 2009 Jun; 10(6):618-26.Nat Immunol2009-05-03T00:00:002009Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Kr?ppel-like factors KLF4 and KLF2.Authorship 702278128170385Mamonkin M, Heslop HENature medicineExhausting alloreactivity of donor-derived CAR T cells. Nat Med. 2017 02 07; 23(2):147-148.Nat Med2017-02-07T00:00:002017Exhausting alloreactivity of donor-derived CAR T cells.Authorship 870163428550199Schmueck-Henneresse M, Omer B, Shum T, Tashiro H, Mamonkin M, Lapteva N, Sharma S, Rollins L, Dotti G, Reinke P, Volk HD, Rooney CMJournal of immunology (Baltimore, Md. : 1950)Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells. J Immunol. 2017 07 01; 199(1):348-362.J Immunol2017-05-26T00:00:002017Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells.Authorship 873451328537234Kulemzin SV, Kuznetsova VV, Mamonkin M, Taranin AV, Gorchakov AAMolekuliarnaia biologiia[CAR T-cell therapy: Balance of efficacy and safety]. Mol Biol (Mosk). 2017 Mar-Apr; 51(2):274-287.Mol Biol (Mosk)2017-03-01T00:00:002017[CAR T-cell therapy: Balance of efficacy and safety].LAURENSCHERERLAUREN SCHERER13112SCHERER, LAURENAssistant ProfessorAuthorship 8766361028539325Gomes-Silva D, Srinivasan M, Sharma S, Lee CM, Wagner DL, Davis TH, Rouce RH, Bao G, Brenner MK, Mamonkin MBloodCD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood. 2017 07 20; 130(3):285-296.Blood2017-05-24T00:00:002017CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies.Authorship 8802031Authorship 8803245Authorship 884753928676343Tashiro H, Sauer T, Shum T, Parikh K, Mamonkin M, Omer B, Rouce RH, Lulla P, Rooney CM, Gottschalk S, Brenner MKMolecular therapy : the journal of the American Society of Gene TherapyTreatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1. Mol Ther. 2017 09 06; 25(9):2202-2213.Mol Ther2017-07-01T00:00:002017Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1.28978471Gomes-Silva D, Mukherjee M, Srinivasan M, Krenciute G, Dakhova O, Zheng Y, Cabral JMS, Rooney CM, Orange JS, Brenner MK, Mamonkin MCell reportsTonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent. Cell Rep. 2017 Oct 03; 21(1):17-26.Cell Rep2017-10-03T00:00:002017Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent.29079655Mamonkin M, Mukherjee M, Srinivasan M, Sharma S, Gomes-Silva D, Mo F, Krenciute G, Orange JS, Brenner MKCancer immunology researchReversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies. Cancer Immunol Res. 2018 01; 6(1):47-58.Cancer Immunol Res2017-10-27T00:00:002017Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.true1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant ProfessorD054218Disorders1193040.760976Precursor T-Cell Lymphoblastic Leukemia-LymphomaD011948Chemicals & Drugs36211400.611886Receptors, Antigen, T-CellD016219Procedures37817300.485543Immunotherapy, AdoptiveAuthorship 9262043Authorship 9375081028461969Kulemzin SV, Kuznetsova VV, Mamonkin M, Taranin AV, Gorchakov AAActa naturaeEngineering Chimeric Antigen Receptors. Acta Naturae. 2017 Jan-Mar; 9(1):6-14.Acta Naturae2017-01-01T00:00:002017Engineering Chimeric Antigen Receptors.30391141Gomes-Silva D, Atilla E, Atilla PA, Mo F, Tashiro H, Srinivasan M, Lulla P, Rouce RH, Cabral JMS, Ramos CA, Brenner MK, Mamonkin MMolecular therapy : the journal of the American Society of Gene TherapyCD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia. Mol Ther. 2019 01 02; 27(1):272-280.Mol Ther2018-10-04T00:00:002018CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia.D013601Anatomy82238330.393288T-LymphocytesCenter for Cell & Gene TherapyDepartment of MedicineDepartment of PediatricsDepartment of Pathology & ImmunologyMedicine-General MedicinePathologyPediatrics-Hem/Onc Cell & Gene ThePediatrics-Hematology & OncologyPediatrics-OncologyBaylor College of MedicineSYEDQUADRISYED QUADRI0.000000000000000.00000000000000290QUADRI, SYEDAssistant ProfessorMALCOLMBRENNERMALCOLM BRENNER0.000000000000000.000000000000003564BRENNER, MALCOLMDistinguished Service ProfessorCLIONAROONEYCLIONA ROONEY0.000000000000000.000000000000003578ROONEY, CLIONAProfessorFRANCISGANNONFRANCIS GANNON0.000000000000000.00000000000000730GANNON, FRANCISProfessorNORMAQUINTANILLANORMA QUINTANILLA0.000000000000000.000000000000001811QUINTANILLA, NORMAAssistant ProfessorMILTONFINEGOLDMILTON FINEGOLD0.000000000000000.000000000000002800FINEGOLD, MILTONProfessor EmeritusHELENHESLOPHELEN HESLOP0.000000000000000.000000000000003566HESLOP, HELENProfessorSTEPHENGOTTSCHALKSTEPHEN GOTTSCHALK0.000000000000000.0000000000000053GOTTSCHALK, STEPHENAdjunct ProfessorSWAPANDASGUPTASWAPAN DASGUPTA0.000000000000000.00000000000000571DASGUPTA, SWAPANAssistant ProfessorAuthorship 943177330891427Scherer LD, Brenner MK, Mamonkin MFrontiers in oncologyChimeric Antigen Receptors for T-Cell Malignancies. Front Oncol. 2019; 9:126.Front Oncol2019-03-05T00:00:002019Chimeric Antigen Receptors for T-Cell Malignancies.Authorship 1249973Authorship 12632315D060846Procedures28370.962507Cell Engineering20933011Kulemzin SV, Zamoshnikova AY, Yurchenko MY, Vitak NY, Najakshin AM, Fayngerts SA, Chikaev NA, Reshetnikova ES, Kashirina NM, Peclo MM, Rutkevich PN, Shevelev AY, Yanushevskaya EV, Baranov KO, Mamonkin M, Vlasik TN, Sidorenko SP, Taranin AV, Mechetina LVImmunology lettersFCRL6 receptor: expression and associated proteins. Immunol Lett. 2011 Jan 30; 134(2):174-82.Immunol Lett2010-10-07T00:00:002010FCRL6 receptor: expression and associated proteins.Authorship 947779231135527Lulla PD, Mamonkin M, Brenner MKCancer journal (Sudbury, Mass.)Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia. Cancer J. 2019 May/Jun; 25(3):199-207.Cancer J2019-05-01T00:00:002019Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.Authorship 9510141831264975Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed NThe Journal of clinical investigationTandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape. J Clin Invest. 2019 Jul 02; 129(8):3464.J Clin Invest2019-07-02T00:00:002019Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape.true1Distinguished Service ProfessorDistinguished Service Professortrue1ProfessorProfessortrue1ProfessorProfessorAuthorship 9608082Authorship 960810131707671Mo F, Mamonkin MMethods in molecular biology (Clifton, N.J.)Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral Vectors. Methods Mol Biol. 2020; 2086:119-130.Methods Mol Biol2020-01-01T00:00:002020Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral Vectors.31707680Calderon H, Mamonkin M, Guedan SMethods in molecular biology (Clifton, N.J.)Analysis of CAR-Mediated Tonic Signaling. Methods Mol Biol. 2020; 2086:223-236.Methods Mol Biol2020-01-01T00:00:002020Analysis of CAR-Mediated Tonic Signaling.Authorship 9760041131953246Batra SA, Rathi P, Guo L, Courtney AN, Fleurence J, Balzeau J, Shaik RS, Nguyen TP, Wu MF, Bulsara S, Mamonkin M, Metelitsa LS, Heczey ACancer immunology researchGlypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma. Cancer Immunol Res. 2020 03; 8(3):309-320.Cancer Immunol Res2020-01-17T00:00:002020Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma.NORIHIROWATANABENORIHIRO WATANABE0.000000000000000.000000000000006385WATANABE, NORIHIROAssistant ProfessorRAYNEROUCERAYNE ROUCE0.000000000000000.000000000000005730ROUCE, RAYNEAssociate ProfessorAuthorship 979045732159399Olbrich H, Theobald SJ, Slabik C, Gerasch L, Schneider A, Mach M, Shum T, Mamonkin M, Stripecke RHuman gene therapyAdult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus Infections. Hum Gene Ther. 2020 04; 31(7-8):423-439.Hum Gene Ther2020-04-01T00:00:002020Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus Infections.Authorship 980207332203679Mo F, Heslop HE, Mamonkin MMolecular therapy : the journal of the American Society of Gene TherapyCRISPR-Edited Immune Effectors: The End of the Beginning. Mol Ther. 2020 04 08; 28(4):995-996.Mol Ther2020-03-22T00:00:002020CRISPR-Edited Immune Effectors: The End of the Beginning.Authorship 9943221432661440Mo F, Watanabe N, McKenna MK, Hicks MJ, Srinivasan M, Gomes-Silva D, Atilla E, Smith T, Ataca Atilla P, Ma R, Quach D, Heslop HE, Brenner MK, Mamonkin MNature biotechnologyEngineered off-the-shelf therapeutic T cells resist host immune rejection. Nat Biotechnol. 2021 01; 39(1):56-63.Nat Biotechnol2020-07-13T00:00:002020Engineered off-the-shelf therapeutic T cells resist host immune rejection.Authorship 9988571132938629Ataca Atilla P, McKenna MK, Tashiro H, Srinivasan M, Mo F, Watanabe N, Simons BW, McLean Stevens A, Redell MS, Heslop HE, Mamonkin M, Brenner MK, Atilla EJournal for immunotherapy of cancerModulating TNFa activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. J Immunother Cancer. 2020 09; 8(2).J Immunother Cancer2020-09-01T00:00:002020Modulating TNFa activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia.Authorship 999864132957114Mamonkin MBloodDetonating T-ALL. Blood. 2020 09 10; 136(11):1218-1219.Blood2020-09-10T00:00:002020Detonating T-ALL.Authorship 1010551233536140Mo F, Mamonkin M, Brenner MK, Heslop HETrends in immunologyTaking T-Cell Oncotherapy Off-the-Shelf. Trends Immunol. 2021 03; 42(3):261-272.Trends Immunol2021-02-01T00:00:002021Taking T-Cell Oncotherapy Off-the-Shelf.Authorship 1014343233750078Watanabe N, Mamonkin MCancer journal (Sudbury, Mass.)Off-the-Shelf Chimeric Antigen Receptor T Cells: How Do We Get There? Cancer J. 2021 Mar-Apr 01; 27(2):176-181.Cancer J2021-03-01T00:00:002021Off-the-Shelf Chimeric Antigen Receptor T Cells: How Do We Get There?Authorship 1015719133795449Mamonkin M, Brenner MKScience (New York, N.Y.)Reversal of exhaustion in engineered T cells. Science. 2021 04 02; 372(6537):34-35.Science2021-04-02T00:00:002021Reversal of exhaustion in engineered T cells.Authorship 10242521834196303Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed NThe Journal of clinical investigationTandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape. J Clin Invest. 2021 07 01; 131(13).J Clin Invest2021-07-01T00:00:002021Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape.Authorship 10345642734840026Pearson AD, Rossig C, Mackall C, Shah NN, Baruchel A, Reaman G, Ricafort R, Heenen D, Bassan A, Berntgen M, Bird N, Bleickardt E, Bouchkouj N, Bross P, Brownstein C, Cohen SB, de Rojas T, Ehrlich L, Fox E, Gottschalk S, Hanssens L, Hawkins DS, Horak ID, Taylor DH, Johnson C, Karres D, Ligas F, Ludwinski D, Mamonkin M, Marshall L, Masouleh BK, Matloub Y, Maude S, McDonough J, Minard-Colin V, Norga K, Nysom K, Pappo A, Pearce L, Pieters R, Pule M, Quint?s-Cardama A, Richardson N, Sch??ler-Lenz M, Scobie N, Sersch MA, Smith MA, Sterba J, Tasian SK, Weigel B, Weiner SL, Zwaan CM, Lesa G, Vassal GEuropean journal of cancer (Oxford, England : 1990)Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer. 2022 01; 160:112-133.Eur J Cancer2021-11-25T00:00:002021Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.Authorship 1036131434955406Atilla PA, McKenna MK, Watanabe N, Mamonkin M, Brenner MK, Atilla ECytotherapyCombinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy. Cytotherapy. 2022 03; 24(3):282-290.Cytotherapy2021-12-23T00:00:002021Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy.Authorship 10387691235325065Steffin DHM, Muhsen IN, Hill LC, Ramos CA, Ahmed N, Hegde M, Wang T, Wu M, Gottschalk S, Whittle SB, Lulla PD, Mamonkin M, Omer B, Rouce RH, Heczey A, Metelitsa LS, Grilley BJ, Robertson C, Torrano V, Lapteva N, Gee AP, Rooney CM, Brenner MK, Heslop HEBloodLong-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24.Blood2022-07-07T00:00:002022Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.Authorship 136676124075846Mamonkin M, Shen Y, Lee PH, Puppi M, Park CS, Lacorazza HDImmunology lettersDifferential roles of KLF4 in the development and differentiation of CD8+ T cells. Immunol Lett. 2013 Nov-Dec; 156(1-2):94-101.Immunol Lett2013-09-25T00:00:002013Differential roles of KLF4 in the development and differentiation of CD8+ T cells.Authorship 1051527235900789Velasquez MP, Mamonkin MBloodCD7 CAR: sword and shield. Blood. 2022 07 28; 140(4):293-294.Blood2022-07-28T00:00:002022CD7 CAR: sword and shield.true1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant ProfessorAuthorship 105761616Authorship 10625194Authorship 106073619Authorship 10566381336086817Watanabe N, Mo F, Zheng R, Ma R, Bray VC, van Leeuwen DG, Sritabal-Ramirez J, Hu H, Wang S, Mehta B, Srinivasan M, Scherer LD, Zhang H, Thakkar SG, Hill LC, Heslop HE, Cheng C, Brenner MK, Mamonkin MMolecular therapy : the journal of the American Society of Gene TherapyFeasibility and preclinical efficacy of CD7-unedited CD7 CAR T?cells for T?cell malignancies. Mol Ther. 2023 01 04; 31(1):24-34.Mol Ther2022-09-09T00:00:002022Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T?cells for T?cell malignancies.36044667Mo F, Watanabe N, Omdahl KI, Burkhardt PM, Ding X, Hayase E, Panoskaltsis-Mortari A, Jenq RR, Heslop HE, Kean LS, Brenner MK, Tkachev V, Mamonkin MBloodEngineering T cells to suppress acute GVHD and?leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 2023 03 09; 141(10):1194-1208.Blood2023-03-09T00:00:002023Engineering T cells to suppress acute GVHD and?leukemia relapse after allogeneic hematopoietic stem cell transplantation.36592718Read JA, Rouce RH, Mo F, Mamonkin M, King KYTransplantation and cellular therapyApoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Ther. 2023 03; 29(3):165.e1-165.e7.Transplant Cell Ther2022-12-31T00:00:002022Apoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell Therapy.35914226Freiwan A, Zoine JT, Crawford JC, Vaidya A, Schattgen SA, Myers JA, Patil SL, Khanlari M, Inaba H, Klco JM, Mullighan CG, Krenciute G, Chockley PJ, Naik S, Langfitt DM, Mamonkin M, Obeng EA, Thomas PG, Gottschalk S, Velasquez MPBloodEngineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies. Blood. 2022 12 22; 140(25):2684-2696.Blood2022-12-22T00:00:002022Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies.true1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professor2Associate ProfessorAssociate Professortrue1Adjunct ProfessorAdjunct ProfessorAuthorship 1072317237261853Wagner DL, Mamonkin MBloodSplendid isolation. Blood. 2023 06 01; 141(22):2665-2666.Blood2023-06-01T00:00:002023Splendid isolation.Authorship 10858482038145560Hill LC, Rouce RH, Wu M, Wang T, Ma R, Zhang H, Mehta B, Lapteva N, Mei Z, Smith TS, Yang L, Srinivasan M, Burkhardt PM, Ramos CA, Lulla PD, Arredondo M, Grilley B, Heslop HE, Brenner MK, Mamonkin MBloodAnti-tumor Efficacy and Safety of Unedited Autologous CD5.CAR T cells in Relapsed/Refractory Mature T-cell Lymphomas. Blood. 2023 Dec 25.Blood2023-12-25T00:00:002023Anti-tumor Efficacy and Safety of Unedited Autologous CD5.CAR T cells in Relapsed/Refractory Mature T-cell Lymphomas.Authorship 1087025538241630Leung WK, Torres Chavez AG, French-Kim M, Shafer P, Mamonkin M, Hill LC, Kuvalekar M, Velazquez Y, Watanabe A, Watanabe N, Hoyos V, Lulla PD, Leen AMBloodTargeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood. 2024 Jan 19.Blood2024-01-19T00:00:002024Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.true1Professor EmeritusProfessor EmeritusAuthorship 1090980738506769Mo F, Tsai CT, Zheng R, Cheng C, Heslop HE, Brenner MK, Mamonkin M, Watanabe NCytotherapyHuman platelet lysate enhances in vivo activity of CAR-Vd2 T cells by reducing cellular senescence and apoptosis. Cytotherapy. 2024 Mar 12.Cytotherapy2024-03-12T00:00:002024Human platelet lysate enhances in vivo activity of CAR-Vd2 T cells by reducing cellular senescence and apoptosis.true1Associate ProfessorAssociate ProfessorAuthorship 142055124338897Mamonkin M, Puppi M, Lacorazza HDEuropean journal of immunologyTranscription factor ELF4 promotes development and function of memory CD8(+) T cells in Listeria monocytogenes infection. Eur J Immunol. 2014 Mar; 44(3):715-27.Eur J Immunol2014-01-13T00:00:002014Transcription factor ELF4 promotes development and function of memory CD8(+) T cells in Listeria monocytogenes infection.